Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.78), $0.22 worse than the analyst estimate of ($1.56). Revenue for the quarter came in at $11.35 million versus the consensus estimate of $9.62 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.